LuminUltra Technologies Ltd. is proud to announce that we’ve submitted our GeneCount® COVID-19 RT-qPCR Assay Kit to the U.S. Food and Drug Administration for Emergency Use Authorization and Health Canada for an Interim Order. With this authorization we’ll be able to provide testing facilities throughout North America with a complete, customizable clinical COVID-19 testing solution…. Read More
The GeneCount® COVID-19 RT-qPCR Assay Kit has been submitted to the U.S. FDA for Emergency Use Authorization and to Health Canada for an Interim Order.
Atlantic Business Magazine has named LuminUltra Technologies Ltd.’s Chairman & CEO, Pat Whalen, to their 2020 Top 50 CEO list. Read the full story here.
Environmental surveillance testing is an important tool to re-open the healthcare industry and keep it open. Learn about its benefits.
NGen has announced $3.5 million in project funding in support of Canada’s COVID-19 response, which includes support for LuminUltra’s scale-up.
Until a COVID-19 Vaccine is Available, Widespread Environmental Testing for SARS-CoV-2, Coupled with Effective Disinfection Regimen, Shortens Path to Preserving Public Confidence and Enabling Facilities to Remain Open Amidst Periodic Flare-Ups New Brunswick, Canada – LuminUltra, the Canadian biotechnology leader and developer of the GeneCount® qPCR system, and Florida-based Source Molecular, a leader in pathogen… Read More
While much of the COVID-19 response to date has been focused on human-to-human transmission of the virus, largely unaddressed to date are the ongoing risks of environmental transmission and the role of environmental monitoring to understand the health of both facilities and people. What is environmental monitoring? Many will be familiar now with the human testing protocol employed by most countries around… Read More
June 20, 2019 – Microbiology control specialist LuminUltra today launched its revolutionary new GeneCount® portfolio of DNA products and services, making it far easier and faster to quantify, specify and target the types of organisms found in all types of water systems, on surfaces and in solid samples. Users of LuminUltra’s 2nd Generation Adenosine… Read More
LuminUltra has acquired aqua-tools’ Rapid Microbial Solutions division, including its B-QUA™ product line for ballast water compliance monitoring.
The aquisition enables one-stop microbiological management using a new combination of technologies and expertise. Learn more.